美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Abivax S.A.

89.05

+2.042.34%

盤後：90.040.9900+1.11%19:59 EDT

成交量：211.08萬

成交額：1.83億

市值：77.52億

市盈率：-15.05

高：89.10

開：86.70

低：84.11

收：87.01

52周最高：148.83

52周最低：69.81

股本：8,705.45萬

流通股本：7,546.89萬

量比：1.73

換手率：2.80%

股息：- -

股息率：- -

每股收益(TTM):-5.9176

每股收益(LYR):-5.6758

淨資產收益率：-252.35%

總資產收益率：-62.88%

市淨率：18.86

市盈率(LYR):-15.69

資料載入中...

總覽公司新聞資訊公告

異動解讀｜Abivax S.A.盤中下跌5.18%，財報不及預期疊加機構下調評級持續承壓

異動解讀｜Abivax S.A.盤中上漲5.1%，報95.705美元

異動解讀｜Abivax S.A.盤中下跌5.28%，上半年每股虧損大幅不及預期持續承壓

異動解讀｜Abivax S.A.盤中下跌5.47%，上半年每股虧損大幅不及預期引發分析師下調目標價

異動解讀｜Abivax S.A.盤中上漲5.06%，機構看多疊加管線進展提振反彈

異動解讀｜Abivax S.A.盤中下跌5.33%，財報前瞻顯示營收預計降逾四成

財報前瞻｜Abivax S.A.本季度營收預計降43.05%，機構觀點偏多

Abivax S.A.：按計劃推進，2026年底前提交Obefazimod治療中重度活動性潰瘍性結腸炎首項新藥申請

異動解讀｜Abivax盤中上漲5.18%，摩根士丹利大幅上調目標價至180美元

Abivax(ABVX)宣佈完成9.2 億美元美股存託憑證增發

異動解讀｜Abivax S.A.盤前上漲6.46%，9.2億美元增發正式交割提振持續做多情緒

異動解讀｜Abivax S.A.夜盤上漲5.74%，9.2億美元增發正式交割提振持續做多情緒

異動解讀｜Abivax S.A.盤中上漲5.39%，承銷商全額行使超額配售權總募資擴至9.2億美元

異動解讀｜Abivax S.A.盤前上漲6.27%，8億美元增發定價完成後市場追捧延續

異動解讀｜Abivax S.A.夜盤上漲6.37%，8億美元增發定價完成後市場追捧延續

美股異動 | 潰瘍性結腸炎療法obefazimod取得積極數據 Abivax S.A.(ABVX.US)暴升逾40%

異動解讀｜Abivax S.A.盤中上漲36.68%，三期維持試驗補充數據積極消除安全性爭議

法國生物科技公司Abivax盤前飆升35%，實驗性藥物最新數據提振市場信心

老虎资讯综合

焦點股追蹤：Strategy、超微電腦、星座品牌

異動解讀｜Abivax S.A.盤前上漲25.85%，三期維持試驗補充數據積極驅動股價加速反彈

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/ABVX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":89.05,"timestamp":1791489600000,"preClose":87.01,"halted":0,"volume":2110754,"hourTrading":{"tag":"盘后","latestPrice":90.04,"preClose":89.05,"latestTime":"19:59 EDT","volume":26971,"amount":2401980.7559,"timestamp":1791503977924,"change":0.99,"changeRate":0.011117,"amplitude":0.015722},"delay":0,"changeRate":0.023445580967704768,"floatShares":75468900,"shares":87054500,"eps":-5.917616,"marketStatus":"已收盤","change":2.04,"latestTime":"10-08 16:00:00 EDT","open":86.7,"high":89.1,"low":84.11,"amount":183233119.42728,"amplitude":0.05735,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.917616,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":5,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":87.01,"preHourTrading":{"tag":"盘前","latestPrice":86.71,"preClose":87.01,"latestTime":"09:28 EDT","volume":4697,"amount":404434.43348,"timestamp":1791466129142,"change":-0.3,"changeRate":-0.003448,"amplitude":0.013217},"postHourTrading":{"tag":"盘后","latestPrice":90.04,"preClose":89.05,"latestTime":"19:59 EDT","volume":26971,"amount":2401980.7559,"timestamp":1791503977924,"change":0.99,"changeRate":0.011117,"amplitude":0.015722},"volumeRatio":1.725294,"impliedVol":0.742,"impliedVolPercentile":0.2749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVX\",,,,,undefined,":{"symbol":"ABVX","floatShares":75468900,"roa":"-62.88%","roe":"-252.35%","lyrEps":-5.675825,"volumeRatio":1.725294,"shares":87054500,"dividePrice":0,"high":89.1,"amplitude":0.05735,"preClose":87.01,"low":84.11,"week52Low":69.81,"pbRate":"18.86","psRate":"1480.09","week52High":148.83,"institutionHeld":0,"latestPrice":89.05,"eps":-5.917616,"divideRate":0,"volume":2110754,"delay":0,"ttmEps":-5.917616,"open":86.7,"prevYearClose":134.855,"prevWeekClose":92.88,"prevMonthClose":99.02,"prevQuarterClose":99.02,"fiveDayClose":95.1,"twentyDayClose":115.95,"sixtyDayClose":136.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-21","symbol":"ABVX","fiscalQuarterEnding":"2026/06","expectedEps":-1.08,"name":null,"time":"盤後","type":"earning","dateTimestamp":1789963200000,"reportTimeType":"post","actualEps":-1.71},{"market":"US","date":"2026-05-22","symbol":"ABVX","fiscalQuarterEnding":"2026/03","expectedEps":-1.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1779422400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-03-23","symbol":"ABVX","fiscalQuarterEnding":"2025/12","expectedEps":-1.7,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774238400000,"reportTimeType":"post","actualEps":-1.19},{"market":"US","date":"2025-12-15","symbol":"ABVX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1765774800000,"reportTimeType":"post","actualEps":-2.45},{"market":"US","date":"2025-09-08","symbol":"ABVX","fiscalQuarterEnding":"2025/06","expectedEps":-0.9,"name":null,"time":"盤後","type":"earning","dateTimestamp":1757304000000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.5385,"hold":0.0769,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5385,"analysts":13,"updateTime":1789012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABVX","date":"2026-10-07","current":-15.04829,"percent":0.421199,"low":-44.789917,"twenty":-27.258554,"median":-7.283933,"eighty":-2.713931,"high":-0.02231,"avg":-14.163388,"sd":11.921724,"marketCap":7668850165.64},"quantilePoints":[{"date":"2023-10-27","current":-7.823172,"twenty":-7.328793,"median":-6.587224,"eighty":-5.845656,"marketCap":753894810.45},{"date":"2023-11-03","current":-6.291292,"twenty":-6.250217,"median":-6.06538,"eighty":-6.010614,"marketCap":611163613.59},{"date":"2023-11-10","current":-6.503512,"twenty":-6.645905,"median":-6.346058,"eighty":-6.06538,"marketCap":637532258.17},{"date":"2023-11-17","current":-7.092251,"twenty":-6.941614,"median":-6.503512,"eighty":-6.069488,"marketCap":704987904.63},{"date":"2023-11-24","current":-6.558278,"twenty":-6.982681,"median":-6.613045,"eighty":-6.085918,"marketCap":654468961.83},{"date":"2023-12-01","current":-6.469283,"twenty":-6.777344,"median":-6.486397,"eighty":-6.085918,"marketCap":645658268.08},{"date":"2023-12-08","current":-6.667811,"twenty":-6.729423,"median":-6.558278,"eighty":-6.270755,"marketCap":658292574.17},{"date":"2023-12-15","current":-6.708886,"twenty":-6.708886,"median":-6.565124,"eighty":-6.291292,"marketCap":675019398.57},{"date":"2023-12-22","current":-6.859493,"twenty":-6.749961,"median":-6.585661,"eighty":-6.304984,"marketCap":690021158.62},{"date":"2023-12-29","current":-6.722577,"twenty":-6.78282,"median":-6.609622,"eighty":-6.321414,"marketCap":681416772.26},{"date":"2024-01-05","current":-6.626736,"twenty":-6.777344,"median":-6.626736,"eighty":-6.346059,"marketCap":664561787.4},{"date":"2024-01-12","current":-6.845802,"twenty":-6.796512,"median":-6.667811,"eighty":-6.407671,"marketCap":685854313.55},{"date":"2024-01-19","current":-7.023793,"twenty":-6.859493,"median":-6.681503,"eighty":-6.435054,"marketCap":698334715.34},{"date":"2024-01-26","current":-7.986412,"twenty":-6.982718,"median":-6.681503,"eighty":-6.435054,"marketCap":792063074.67},{"date":"2024-02-02","current":-8.137618,"twenty":-7.092251,"median":-6.715732,"eighty":-6.469283,"marketCap":807847078.54},{"date":"2024-02-09","current":-7.972666,"twenty":-7.379774,"median":-6.743115,"eighty":-6.503512,"marketCap":785337680.3},{"date":"2024-02-16","current":-7.738985,"twenty":-7.738985,"median":-6.763653,"eighty":-6.503512,"marketCap":761909093.06},{"date":"2024-02-23","current":-8.385046,"twenty":-7.788813,"median":-6.78419,"eighty":-6.508989,"marketCap":829978945.38},{"date":"2024-03-01","current":-8.879901,"twenty":-7.848771,"median":-6.818419,"eighty":-6.548694,"marketCap":878391233.38},{"date":"2024-03-08","current":-8.921139,"twenty":-7.986412,"median":-6.859493,"eighty":-6.569232,"marketCap":892211380.33},{"date":"2024-03-15","current":-8.659965,"twenty":-8.228342,"median":-6.982681,"eighty":-6.577447,"marketCap":863166780.31},{"date":"2024-03-22","current":-9.319772,"twenty":-8.319065,"median":-7.010102,"eighty":-6.584292,"marketCap":926107447.06},{"date":"2024-03-28","current":-9.209804,"twenty":-8.585737,"median":-7.078559,"eighty":-6.597984,"marketCap":910336135.23},{"date":"2024-04-05","current":-9.732151,"twenty":-8.736943,"median":-7.311316,"eighty":-6.610307,"marketCap":967400801.65},{"date":"2024-04-12","current":-5.879845,"twenty":-8.706701,"median":-7.078559,"eighty":-6.566493,"marketCap":928230894.29},{"date":"2024-04-19","current":-6.030284,"twenty":-8.692955,"median":-6.99641,"eighty":-6.48982,"marketCap":950004364.47},{"date":"2024-04-26","current":-6.311356,"twenty":-8.670962,"median":-6.941624,"eighty":-6.433272,"marketCap":998864220.67},{"date":"2024-05-03","current":-5.987697,"twenty":-8.585737,"median":-6.859493,"eighty":-6.311356,"marketCap":946423801.22},{"date":"2024-05-10","current":-5.698107,"twenty":-8.470271,"median":-6.80815,"eighty":-6.289097,"marketCap":907055615.77},{"date":"2024-05-17","current":-5.502208,"twenty":-8.401541,"median":-6.777344,"eighty":-6.21545,"marketCap":883582818.48},{"date":"2024-05-24","current":-5.348896,"twenty":-8.33556,"median":-6.749961,"eighty":-6.06538,"marketCap":855336978.03},{"date":"2024-05-31","current":-5.357413,"twenty":-8.297072,"median":-6.736269,"eighty":-6.030284,"marketCap":858278233.57},{"date":"2024-06-07","current":-5.493691,"twenty":-8.288824,"median":-6.708886,"eighty":-5.988933,"marketCap":883175015.23},{"date":"2024-06-14","current":-5.042271,"twenty":-8.277827,"median":-6.681503,"eighty":-5.938296,"marketCap":801878490.85},{"date":"2024-06-21","current":-5.510725,"twenty":-8.253084,"median":-6.681503,"eighty":-5.777439,"marketCap":872433075.44},{"date":"2024-06-28","current":-4.974132,"twenty":-8.244837,"median":-6.681503,"eighty":-5.74004,"marketCap":786723361.52},{"date":"2024-07-05","current":-5.306309,"twenty":-8.203599,"median":-6.667811,"eighty":-5.629968,"marketCap":847517911.35},{"date":"2024-07-12","current":-5.408517,"twenty":-8.118374,"median":-6.619891,"eighty":-5.595899,"marketCap":868631706.71},{"date":"2024-07-15","current":-5.417034,"twenty":-8.099129,"median":-6.613045,"eighty":-5.590788,"marketCap":873513053.92},{"date":"2024-08-02","current":-4.676203,"twenty":-8.079885,"median":-6.609622,"eighty":-5.583974,"marketCap":745105907.03},{"date":"2024-08-09","current":-4.513478,"twenty":-8.008406,"median":-6.578816,"eighty":-5.515836,"marketCap":727494223.22},{"date":"2024-08-16","current":-4.316495,"twenty":-7.986412,"median":-6.534318,"eighty":-5.490284,"marketCap":700482151.8},{"date":"2024-08-23","current":-4.453526,"twenty":-7.978164,"median":-6.503512,"eighty":-5.44429,"marketCap":730827498.61},{"date":"2024-08-30","current":-4.898879,"twenty":-7.906686,"median":-6.449861,"eighty":-5.413627,"marketCap":801684090.61},{"date":"2024-09-06","current":-4.667638,"twenty":-7.862699,"median":-6.432827,"eighty":-5.36082,"marketCap":764519824.83},{"date":"2024-09-13","current":-3.822511,"twenty":-7.855735,"median":-6.332367,"eighty":-5.335268,"marketCap":748409890.75},{"date":"2024-09-20","current":-3.623827,"twenty":-7.841256,"median":-6.30817,"eighty":-5.285867,"marketCap":716147844.73},{"date":"2024-09-27","current":-3.630961,"twenty":-7.835207,"median":-6.291292,"eighty":-5.156403,"marketCap":720043812.45},{"date":"2024-10-04","current":-3.210083,"twenty":-7.830393,"median":-6.281546,"eighty":-4.898879,"marketCap":627325694.46},{"date":"2024-10-11","current":-2.96041,"twenty":-7.805992,"median":-6.132492,"eighty":-4.671064,"marketCap":573856377.14},{"date":"2024-10-18","current":-3.434789,"twenty":-7.774725,"median":-6.075649,"eighty":-4.6094,"marketCap":659899758.53},{"date":"2024-10-25","current":-3.324219,"twenty":-7.75548,"median":-6.033455,"eighty":-4.49121,"marketCap":637070240.87},{"date":"2024-10-31","current":-3.438356,"twenty":-7.738985,"median":-6.030284,"eighty":-4.463804,"marketCap":662378132.46},{"date":"2024-11-08","current":-3.427655,"twenty":-7.738985,"median":-5.993854,"eighty":-4.429546,"marketCap":655972131.38},{"date":"2024-11-15","current":-3.106647,"twenty":-7.711493,"median":-5.970662,"eighty":-4.328485,"marketCap":583153684.93},{"date":"2024-11-22","current":-3.010345,"twenty":-7.590528,"median":-5.940851,"eighty":-3.765459,"marketCap":560275247.04},{"date":"2024-11-29","current":-2.837956,"twenty":-7.546541,"median":-5.882667,"eighty":-3.688029,"marketCap":531199944.09},{"date":"2024-12-06","current":-2.848666,"twenty":-7.379774,"median":-5.732176,"eighty":-3.623827,"marketCap":534218918.72},{"date":"2024-12-13","current":-2.548806,"twenty":-7.311316,"median":-5.65552,"eighty":-3.566759,"marketCap":474325506.61},{"date":"2024-12-20","current":-2.520248,"twenty":-7.311316,"median":-5.604416,"eighty":-3.452623,"marketCap":464239022.01},{"date":"2024-12-27","current":-2.516678,"twenty":-7.267503,"median":-5.595899,"eighty":-3.437643,"marketCap":465029850.03},{"date":"2025-01-03","current":-2.49883,"twenty":-7.157971,"median":-5.578864,"eighty":-3.421948,"marketCap":454676281.41},{"date":"2025-01-10","current":-2.309632,"twenty":-7.081298,"median":-5.52776,"eighty":-3.400548,"marketCap":421851498.87},{"date":"2025-01-17","current":-2.156736,"twenty":-7.048438,"median":-5.506467,"eighty":-3.355607,"marketCap":393925230.6},{"date":"2025-01-24","current":-2.178161,"twenty":-7.018316,"median":-5.493691,"eighty":-3.318513,"marketCap":402353167.1},{"date":"2025-01-31","current":-2.156736,"twenty":-6.993672,"median":-5.459621,"eighty":-3.135894,"marketCap":398893952.88},{"date":"2025-02-07","current":-2.038902,"twenty":-6.982711,"median":-5.442586,"eighty":-3.053859,"marketCap":375339390.95},{"date":"2025-02-14","current":-2.431685,"twenty":-6.966258,"median":-5.417034,"eighty":-3.014625,"marketCap":450591803.66},{"date":"2025-02-21","current":-2.725249,"twenty":-6.900568,"median":-5.408517,"eighty":-2.924742,"marketCap":505993414.61},{"date":"2025-02-28","current":-2.478798,"twenty":-6.859493,"median":-5.361671,"eighty":-2.877224,"marketCap":457649034.34},{"date":"2025-03-07","current":-2.62524,"twenty":-6.859493,"median":-5.348896,"eighty":-2.848666,"marketCap":504421902.75},{"date":"2025-03-14","current":-1.950178,"twenty":-6.845802,"median":-5.331861,"eighty":-2.792772,"marketCap":375893933.73},{"date":"2025-03-21","current":-2.425222,"twenty":-6.818419,"median":-5.306309,"eighty":-2.725249,"marketCap":466899893.66},{"date":"2025-03-28","current":-2.16502,"twenty":-6.797881,"median":-5.23817,"eighty":-2.643099,"marketCap":411881933.29},{"date":"2025-04-04","current":-1.798189,"twenty":-6.791035,"median":-5.118927,"eighty":-2.598783,"marketCap":350804145.45},{"date":"2025-04-11","current":-1.7874,"twenty":-6.777344,"median":-4.936505,"eighty":-2.541667,"marketCap":352326323.68},{"date":"2025-04-17","current":-1.884502,"twenty":-6.777344,"median":-4.813235,"eighty":-2.527388,"marketCap":377676205.37},{"date":"2025-04-25","current":-2.187427,"twenty":-6.755438,"median":-4.676203,"eighty":-2.49883,"marketCap":437738722.61},{"date":"2025-05-02","current":-2.334934,"twenty":-6.749961,"median":-4.641945,"eighty":-2.473083,"marketCap":464043181.1},{"date":"2025-05-09","current":-2.219807,"twenty":-6.744484,"median":-4.599123,"eighty":-2.430392,"marketCap":441113036.42},{"date":"2025-05-16","current":-1.936126,"twenty":-6.732161,"median":-4.504914,"eighty":-2.406016,"marketCap":381685399.33},{"date":"2025-05-23","current":-1.820966,"twenty":-6.723946,"median":-4.470655,"eighty":-2.350016,"marketCap":362101694.69},{"date":"2025-05-30","current":-1.900139,"twenty":-6.714362,"median":-4.462091,"eighty":-2.329767,"marketCap":380507035.56},{"date":"2025-06-06","current":-2.513168,"twenty":-6.708886,"median":-4.444961,"eighty":-2.329767,"marketCap":534533766.17},{"date":"2025-06-13","current":-1.97798,"twenty":-6.692456,"median":-4.410704,"eighty":-2.276706,"marketCap":425231303.24},{"date":"2025-06-20","current":-1.793505,"twenty":-6.681503,"median":-4.342188,"eighty":-2.264946,"marketCap":382035064.22},{"date":"2025-06-27","current":-2.138541,"twenty":-6.681503,"median":-4.299366,"eighty":-2.248589,"marketCap":464697383.01},{"date":"2025-07-03","current":-2.289493,"twenty":-6.681503,"median":-3.786854,"eighty":-2.248786,"marketCap":500190485.77},{"date":"2025-07-11","current":-2.429597,"twenty":-6.678765,"median":-3.702296,"eighty":-2.250599,"marketCap":527449091.87},{"date":"2025-07-18","current":-2.945587,"twenty":-6.667811,"median":-3.641661,"eighty":-2.25491,"marketCap":634057320.66},{"date":"2025-07-25","current":-23.061864,"twenty":-6.681503,"median":-3.652361,"eighty":-2.257399,"marketCap":5041932651.84},{"date":"2025-08-01","current":-24.891124,"twenty":-6.708886,"median":-3.72013,"eighty":-2.264403,"marketCap":5288723102.26},{"date":"2025-08-08","current":-24.565749,"twenty":-6.748592,"median":-3.822511,"eighty":-2.266806,"marketCap":5307007573.85},{"date":"2025-08-15","current":-24.412019,"twenty":-6.788297,"median":-4.320777,"eighty":-2.26785,"marketCap":5283013491.79},{"date":"2025-08-22","current":-27.056654,"twenty":-6.856755,"median":-4.350753,"eighty":-2.269596,"marketCap":5836300408.78},{"date":"2025-08-29","current":-27.951762,"twenty":-6.982711,"median":-4.432115,"eighty":-2.275271,"marketCap":6054693876.38},{"date":"2025-09-05","current":-31.125324,"twenty":-7.064868,"median":-4.453526,"eighty":-2.278142,"marketCap":6729569738.1},{"date":"2025-09-12","current":-27.34583,"twenty":-7.311316,"median":-4.470655,"eighty":-2.289493,"marketCap":6274864374.63},{"date":"2025-09-19","current":-27.152436,"twenty":-7.738985,"median":-4.492066,"eighty":-2.306579,"marketCap":6253253490.1},{"date":"2025-09-26","current":-27.191115,"twenty":-7.780223,"median":-4.581994,"eighty":-2.309632,"marketCap":6202939418.56},{"date":"2025-10-03","current":-27.92601,"twenty":-7.845289,"median":-4.624816,"eighty":-2.312121,"marketCap":6384002898.09},{"date":"2025-10-10","current":-30.594839,"twenty":-7.986412,"median":-4.667638,"eighty":-2.323665,"marketCap":6912424239.13},{"date":"2025-10-17","current":-30.362767,"twenty":-8.220094,"median":-4.710461,"eighty":-2.327411,"marketCap":6924043391.69},{"date":"2025-10-24","current":-30.633518,"twenty":-8.30257,"median":-4.898879,"eighty":-2.331337,"marketCap":6947674791.64},{"date":"2025-10-31","current":-35.158924,"twenty":-8.659965,"median":-5.080599,"eighty":-2.331337,"marketCap":7943607628.35},{"date":"2025-11-07","current":-34.191957,"twenty":-8.769933,"median":-5.221135,"eighty":-2.334934,"marketCap":7707312075.45},{"date":"2025-11-14","current":-36.435321,"twenty":-8.934885,"median":-5.289274,"eighty":-2.340751,"marketCap":8287572122.24},{"date":"2025-11-21","current":-39.68433,"twenty":-9.168566,"median":-5.331861,"eighty":-2.344168,"marketCap":8947428940.69},{"date":"2025-11-28","current":-41.772979,"twenty":-9.226299,"median":-5.340378,"eighty":-2.351863,"marketCap":9466410187.89},{"date":"2025-12-05","current":-36.473999,"twenty":-9.286782,"median":-5.354345,"eighty":-2.35938,"marketCap":8310882570.26},{"date":"2025-12-12","current":-41.850337,"twenty":-9.520464,"median":-5.382965,"eighty":-2.371798,"marketCap":9611017354.25},{"date":"2025-12-19","current":-26.516104,"twenty":-20.549981,"median":-5.417034,"eighty":-2.383656,"marketCap":9139275129.17},{"date":"2025-12-26","current":-32.349646,"twenty":-23.956328,"median":-5.429811,"eighty":-2.389415,"marketCap":11186696717.72},{"date":"2026-01-02","current":-30.493519,"twenty":-24.259916,"median":-5.455362,"eighty":-2.392505,"marketCap":10512635312.43},{"date":"2026-01-09","current":-26.250942,"twenty":-24.408436,"median":-5.485173,"eighty":-2.400028,"marketCap":8979345802.35},{"date":"2026-01-16","current":-27.099458,"twenty":-24.671496,"median":-5.49795,"eighty":-2.410756,"marketCap":9234075745.3},{"date":"2026-01-23","current":-28.266166,"twenty":-24.923661,"median":-5.514984,"eighty":-2.41264,"marketCap":9748190743.74},{"date":"2026-01-30","current":-25.137266,"twenty":-25.338253,"median":-5.570347,"eighty":-2.413186,"marketCap":8803591875.67},{"date":"2026-02-06","current":-25.694104,"twenty":-25.420854,"median":-5.59164,"eighty":-2.415525,"marketCap":8892505001.77},{"date":"2026-02-13","current":-28.160102,"twenty":-25.842594,"median":-5.604416,"eighty":-2.424554,"marketCap":9808417129.46},{"date":"2026-02-20","current":-29.8041,"twenty":-26.038814,"median":-5.612933,"eighty":-2.425222,"marketCap":10293092752.09},{"date":"2026-02-27","current":-27.205522,"twenty":-26.533578,"median":-5.732176,"eighty":-2.429597,"marketCap":9418925305.5},{"date":"2026-03-06","current":-24.925137,"twenty":-26.516104,"median":-5.879845,"eighty":-2.431685,"marketCap":8459789891.3},{"date":"2026-03-13","current":-26.834297,"twenty":-26.533578,"median":-5.940851,"eighty":-2.439509,"marketCap":9079426835.73},{"date":"2026-03-20","current":-29.008617,"twenty":-26.834297,"median":-5.970662,"eighty":-2.463662,"marketCap":9819639406.07},{"date":"2026-03-27","current":-21.015395,"twenty":-26.834297,"median":-5.993854,"eighty":-2.464511,"marketCap":8146846911.19},{"date":"2026-04-02","current":-23.889698,"twenty":-26.791871,"median":-6.021767,"eighty":-2.473083,"marketCap":9269655072.73},{"date":"2026-04-10","current":-25.421089,"twenty":-26.781265,"median":-6.033455,"eighty":-2.478084,"marketCap":9995412686.01},{"date":"2026-04-17","current":-24.667173,"twenty":-26.643534,"median":-6.075649,"eighty":-2.488644,"marketCap":9762937178.52},{"date":"2026-04-24","current":-22.617465,"twenty":-26.548683,"median":-6.132492,"eighty":-2.497285,"marketCap":8904504345.79},{"date":"2026-05-01","current":-22.723485,"twenty":-26.519599,"median":-6.281546,"eighty":-2.49883,"marketCap":8959888176.91},{"date":"2026-05-08","current":-24.855652,"twenty":-26.431252,"median":-6.291292,"eighty":-2.49883,"marketCap":9832902989.64},{"date":"2026-05-15","current":-23.336041,"twenty":-26.388826,"median":-6.30817,"eighty":-2.5103,"marketCap":9155235319.25},{"date":"2026-05-22","current":-25.110387,"twenty":-26.341097,"median":-6.332367,"eighty":-2.515976,"marketCap":9778300609.43},{"date":"2026-05-29","current":-27.204576,"twenty":-26.452465,"median":-6.430599,"eighty":-2.51882,"marketCap":10531826440.97},{"date":"2026-06-05","current":-21.07515,"twenty":-26.452465,"median":-6.449861,"eighty":-2.524532,"marketCap":8138996627.53},{"date":"2026-06-12","current":-20.403432,"twenty":-26.394129,"median":-6.503512,"eighty":-2.527388,"marketCap":7810578705.92},{"date":"2026-06-18","current":-20.679316,"twenty":-26.366489,"median":-6.510358,"eighty":-2.527388,"marketCap":7884389896.71},{"date":"2026-06-26","current":-20.271488,"twenty":-26.33676,"median":-6.575393,"eighty":-2.530811,"marketCap":7666425554.42},{"date":"2026-07-02","current":-30.659126,"twenty":-26.404736,"median":-6.59593,"eighty":-2.53709,"marketCap":11655941374.46},{"date":"2026-07-10","current":-31.890615,"twenty":-26.746832,"median":-6.626736,"eighty":-2.543095,"marketCap":12110267741.2},{"date":"2026-07-17","current":-30.930523,"twenty":-26.834297,"median":-6.667811,"eighty":-2.55052,"marketCap":11755084937.65},{"date":"2026-07-24","current":-29.269824,"twenty":-26.959814,"median":-6.681503,"eighty":-2.564944,"marketCap":11055640094.37},{"date":"2026-07-31","current":-27.583176,"twenty":-27.075079,"median":-6.681503,"eighty":-2.595213,"marketCap":10549310515.77},{"date":"2026-08-07","current":-29.607153,"twenty":-27.191115,"median":-6.715732,"eighty":-2.598783,"marketCap":11333828453.56},{"date":"2026-08-14","current":-26.649033,"twenty":-27.205522,"median":-6.743115,"eighty":-2.618096,"marketCap":10213208013.38},{"date":"2026-08-21","current":-28.220286,"twenty":-27.205522,"median":-6.763653,"eighty":-2.62524,"marketCap":10949286420.23},{"date":"2026-08-28","current":-27.431695,"twenty":-27.34583,"median":-6.791035,"eighty":-2.632383,"marketCap":10616040493.94},{"date":"2026-09-04","current":-27.488023,"twenty":-27.431695,"median":-6.83211,"eighty":-2.643099,"marketCap":10613111685.26},{"date":"2026-09-11","current":-26.578494,"twenty":-27.424889,"median":-6.859493,"eighty":-2.653339,"marketCap":10266716010.47},{"date":"2026-09-18","current":-23.876041,"twenty":-27.418758,"median":-6.982681,"eighty":-2.667322,"marketCap":9106338552.24},{"date":"2026-09-25","current":-17.795318,"twenty":-27.360194,"median":-7.010102,"eighty":-2.675889,"marketCap":8117100899.27},{"date":"2026-10-02","current":-18.142968,"twenty":-27.276009,"median":-7.092251,"eighty":-2.700572,"marketCap":8195547467.91},{"date":"2026-10-07","current":-17.078291,"twenty":-27.258554,"median":-7.283933,"eighty":-2.713931,"marketCap":7668850165.64}],"updateTime":1791501623819},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABVX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196514249","title":"異動解讀｜Abivax S.A.盤中下跌5.18%，財報不及預期疊加機構下調評級持續承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=1196514249","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196514249?lang=zh_tw&edition=fundamental","pubTime":"2026-10-01 22:39","pubTimestamp":1790865589,"startTime":"0","endTime":"0","summary":"10月1日，Abivax S.A.盘中下跌5.18%，报93.89美元/股，成交额2931.93万美元。财报发布后，Wedbush将目标价从160美元下调至118美元，Truist下调至151美元；此后Wall Street Zen进一步将评级由\"持有\"下调至\"卖出\"，多重利空持续压制股价表现。Abivax S.A.是一家临床阶段的生物技术公司，专注于开发利用人体自然调节机制来稳定慢性炎症性疾病免疫反应的疗法，其核心候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段，公司计划于年底前提交新药上市申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报巨亏叠加评级下调，Abivax承压走低","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121989318","title":"異動解讀｜Abivax S.A.盤中上漲5.1%，報95.705美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121989318","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121989318?lang=zh_tw&edition=fundamental","pubTime":"2026-09-28 22:25","pubTimestamp":1790605540,"startTime":"0","endTime":"0","summary":"9月28日，Abivax S.A.盘中上涨5.1%，报95.705美元/股，成交额4374.82万美元。Abivax S.A.所在的生物科技行业中，个股表现分化，其中Kodiak Sciences Inc.涨153.06%，Moderna, Inc.跌2.6%，安进跌0.14%，吉利德科学跌0.25%，再生元制药公司跌3.45%。Abivax S.A.是一家临床阶段的生物技术公司，专注于开发利用人体自然调节机制来稳定慢性炎症性疾病免疫反应的疗法，其主要候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段，公司计划于年底前提交新药上市申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174215564","title":"異動解讀｜Abivax S.A.盤中下跌5.28%，上半年每股虧損大幅不及預期持續承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=1174215564","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174215564?lang=zh_tw&edition=fundamental","pubTime":"2026-09-24 00:51","pubTimestamp":1790182273,"startTime":"0","endTime":"0","summary":"9月23日，Abivax S.A.盘中下跌5.28%，报93.1美元/股，成交额1.13亿美元。尽管销售额295.9万美元超出预期186万美元，但巨额亏损引发持续抛压。此外，公司宣布首席医疗官Fabio Cataldi将于第四季度离任，由Chris Rabbat接任，管理层变动进一步加剧市场不确定性。Abivax S.A.是一家临床阶段生物科技公司，核心候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段，公司计划于年底前提交新药上市申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Abivax亏损远超预期，盘中承压下跌","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199623756","title":"異動解讀｜Abivax S.A.盤中下跌5.47%，上半年每股虧損大幅不及預期引發分析師下調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1199623756","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199623756?lang=zh_tw&edition=fundamental","pubTime":"2026-09-22 21:46","pubTimestamp":1790084808,"startTime":"0","endTime":"0","summary":"9月22日，Abivax S.A.盘中下跌5.47%，报97.795美元/股，成交额2800.2万美元。消息面上，公司公布上半年财报，每股亏损2.43美元，远超市场预期的亏损1.08美元，偏差幅度达125%，较去年同期每股亏损1.47美元进一步扩大65.31%。尽管收入端表现尚可，但亏损大幅超预期引发市场担忧。Abivax S.A.是一家临床阶段生物科技公司，专注于开发利用人体自然调节机制稳定慢性炎症性疾病免疫反应的疗法，核心候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"亏损远超预期，Abivax遭投行下调目标价","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194775209","title":"異動解讀｜Abivax S.A.盤中上漲5.06%，機構看多疊加管線進展提振反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=1194775209","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194775209?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 23:39","pubTimestamp":1789659563,"startTime":"0","endTime":"0","summary":"9月17日，Abivax S.A.盘中上涨5.06%，报107.4美元/股，成交额4550.79万美元。此前公司股价因财报营收预计下降逾四成的预期一度下挫超5%，本次反弹或受机构看多观点及核心管线积极进展提振。公司已明确计划于年底前向监管机构提交obefazimod首项新药申请，同时已完成约9.2亿美元ADS发行，净募资约8.74亿美元，可支持运营至2029年第四季度，现金流安全边际充裕。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩上调目标价，管线进展催化反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191502299","title":"異動解讀｜Abivax S.A.盤中下跌5.33%，財報前瞻顯示營收預計降逾四成","url":"https://stock-news.laohu8.com/highlight/detail?id=1191502299","media":"行情直击","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191502299?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 22:05","pubTimestamp":1789481124,"startTime":"0","endTime":"0","summary":"9月15日，Abivax S.A.盘中下跌5.33%，报107.6美元/股，成交额3131.06万美元。消息面上，公司将于9月21日盘后发布财报，市场一致预期显示本季度营收约67.89万欧元，同比下降43.05%；调整后每股亏损预计为1.06欧元，同比扩大33.33%；息税前利润预计为-5559.27万欧元，同比收窄15.29%。财报发布在即，营收大幅下滑的预期或令部分资金选择提前离场观望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报在即营收预降，Abivax盘中承压","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197355785","title":"財報前瞻｜Abivax S.A.本季度營收預計降43.05%，機構觀點偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1197355785","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197355785?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 08:01","pubTimestamp":1789344111,"startTime":"0","endTime":"0","summary":"Abivax S.A.将于2026年09月21日（盘后）发布财报，市场关注亏损收窄节奏、现金流安全边际及核心管线进度。市场一致预期显示，本季度Abivax S.A.营收预计为67.89万欧元，同比-43.05%；调整后每股收益预计为-1.06欧元，同比变动-33.33%；息税前利润预计为-5,559.27万欧元，同比收窄15.29%。上季度Abivax S.A.营收为99.40万欧元，同比0.00%；毛利率为100.00%；归属母公司股东的净利润为-4,846.80万欧元；调整后每股收益为-0.61欧元，同比变动+26.51%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Abivax S.A.本季度营收预计降43.05%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192804453","title":"Abivax S.A.：按計劃推進，2026年底前提交Obefazimod治療中重度活動性潰瘍性結腸炎首項新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1192804453","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192804453?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 04:13","pubTimestamp":1785442392,"startTime":"0","endTime":"0","summary":"Abivax S.A. 正稳步推进其研发管线。该公司重申，其目标明确——计划于2026年底前，正式向监管机构提交Obefazimod的首项新药申请（NDA）。这项申请旨在寻求该药物用于治疗中重度活动性溃疡性结肠炎（UC）的上市许可。这一进展，标志着公司在关键临床项目上迈出了坚实的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100782164","title":"異動解讀｜Abivax盤中上漲5.18%，摩根士丹利大幅上調目標價至180美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100782164","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100782164?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 23:00","pubTimestamp":1785423618,"startTime":"0","endTime":"0","summary":"7月30日，Abivax盘中上涨5.18%，报124.295美元/股，成交额5488.63万美元。消息面上，摩根士丹利近日发布研报，将Abivax目标价从132美元大幅上调至180美元，维持\"增持\"评级。此外，此前市场对标签限制及监管风险的担忧已随临床数据改善而缓解。公司7月初完成约9.2亿美元ADS发行，资金可支撑运营至2029年第四季度，为obefazimod美国商业化提供充足弹药。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649899419","title":"Abivax(ABVX)宣佈完成9.2 億美元美股存託憑證增發","url":"https://stock-news.laohu8.com/highlight/detail?id=2649899419","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649899419?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 18:08","pubTimestamp":1783418915,"startTime":"0","endTime":"0","summary":"金吾财讯 | 法美临床阶段生物药企 Abivax 公告美国存托凭证承销公开发行正式完成，承销商全额行使超额配售权，本次发行合计募资总额9.2 亿美元，扣除承销佣金与发行费用后净募资约 8.741 亿美元，大幅拉长公司研发现金跑道。本次共计发行 736 万份 ADS，每份对应公司 1 股普通股，全部由 Abivax 自身发售。公司股票两地双重上市，普通股在巴黎泛欧交易所挂牌，ADS 于纳斯达克全球市场交易。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/OGE4NjMzOTE0MzMzMjk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/OGE4NjMzOTE0MzMzMjk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302263","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114490786","title":"異動解讀｜Abivax S.A.盤前上漲6.46%，9.2億美元增發正式交割提振持續做多情緒","url":"https://stock-news.laohu8.com/highlight/detail?id=1114490786","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114490786?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 16:06","pubTimestamp":1783325216,"startTime":"0","endTime":"0","summary":"7月6日，Abivax S.A.盘前上涨6.46%，报152.5美元/股，成交额58.0万美元。消息面上，公司此前宣布承销商全额行使超额配售权，额外购入96万股ADS，总募资规模从8亿美元扩大至约9.2亿美元，净募集资金约8.74亿美元，该发行于本周一正式完成交割。此前公司公布ABTECT维持试验Part 2积极数据消除安全性争议，叠加发行规模由最初6亿美元两度上调并获超额配售全额认购，机构需求旺盛持续强化市场信心，股价维持在125美元发行价上方运行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165938491","title":"異動解讀｜Abivax S.A.夜盤上漲5.74%，9.2億美元增發正式交割提振持續做多情緒","url":"https://stock-news.laohu8.com/highlight/detail?id=1165938491","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165938491?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:01","pubTimestamp":1783321284,"startTime":"0","endTime":"0","summary":"7月6日，Abivax S.A.夜盘上涨5.74%，报152.96美元/股，成交额100.17万美元。消息面上，公司此前宣布承销商全额行使超额配售权，额外购入96万股ADS，总募资规模从8亿美元扩大至约9.2亿美元，净募集资金约8.74亿美元，该发行于本周一正式完成交割。此前公司公布ABTECT维持试验Part 2积极数据，消除安全性争议后股价已大幅反弹，叠加发行规模由最初6亿美元两度上调并获超额配售全额认购，机构需求旺盛持续强化市场信心，股价维持在125美元发行价上方运行。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189220198","title":"異動解讀｜Abivax S.A.盤中上漲5.39%，承銷商全額行使超額配售權總募資擴至9.2億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189220198","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189220198?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 21:36","pubTimestamp":1782999412,"startTime":"0","endTime":"0","summary":"7月2日，Abivax S.A.盘中上涨5.39%，报140.67美元/股，成交额6686.63万美元。消息面上，公司宣布其ADS公开发行的承销商已全额行使超额配售权，额外购买96万股ADS，总募集金额从8亿美元提升至约9.2亿美元，预计下周一完成交割。此前公司公布ABTECT维持试验积极数据消除安全性争议，股价已大幅反弹，当前股价持续高于每股125美元的发行价运行，超额配售全额行使进一步强化市场信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123159008","title":"異動解讀｜Abivax S.A.盤前上漲6.27%，8億美元增發定價完成後市場追捧延續","url":"https://stock-news.laohu8.com/highlight/detail?id=1123159008","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123159008?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 16:05","pubTimestamp":1782979503,"startTime":"0","endTime":"0","summary":"7月2日，Abivax S.A.盘前上涨6.27%，报140.88美元/股，成交额42.52万美元。消息面上，公司完成8亿美元ADS公开发行定价，以每股125美元发行640万股美国存托凭证，发行规模从此前的6亿美元上调至8亿美元，显示机构认购需求旺盛。募集资金将主要用于核心药物obefazimod在美国的商业化推进及溃疡性结肠炎和克罗恩病的临床研发。此前公司公布ABTECT维持试验积极数据消除安全性争议，股价已大幅反弹超38%，本次增发超额扩容进一步确认市场信心，当前股价持续高于发行价运行。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140015042","title":"異動解讀｜Abivax S.A.夜盤上漲6.37%，8億美元增發定價完成後市場追捧延續","url":"https://stock-news.laohu8.com/highlight/detail?id=1140015042","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140015042?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 15:05","pubTimestamp":1782975924,"startTime":"0","endTime":"0","summary":"7月2日，Abivax S.A.夜盘上涨6.37%，报141.0美元/股，成交额41.41万美元。消息面上，公司完成8亿美元ADS公开发行定价，以每股125美元发行640万股美国存托凭证，发行规模从此前的6亿美元上调至8亿美元，显示机构认购需求旺盛。募集资金将主要用于核心药物obefazimod在美国的商业化推进及溃疡性结肠炎和克罗恩病的临床研发。此前公司公布ABTECT维持试验积极数据消除安全性争议，股价已大幅反弹超38%，本次增发超额扩容进一步确认市场信心，当前股价持续高于发行价运行。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647557096","title":"美股異動 | 潰瘍性結腸炎療法obefazimod取得積極數據 Abivax S.A.(ABVX.US)暴升逾40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647557096","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647557096?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 23:06","pubTimestamp":1782831981,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150042476","title":"異動解讀｜Abivax S.A.盤中上漲36.68%，三期維持試驗補充數據積極消除安全性爭議","url":"https://stock-news.laohu8.com/highlight/detail?id=1150042476","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150042476?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 21:31","pubTimestamp":1782826310,"startTime":"0","endTime":"0","summary":"6月30日，Abivax S.A.盘中上涨36.68%，报131.53美元/股，成交额1.81亿美元。此前50mg组曾因报告多例癌症病例致股价从130美元附近暴跌至约70美元，本次数据消除安全性新增隐患，前期争议逐步消化，多头情绪加速升温。此外，Wedbush将目标价从90美元上调至110美元。公司表示仍计划于第四季度向FDA提交新药上市申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178186665","title":"法國生物科技公司Abivax盤前飆升35%，實驗性藥物最新數據提振市場信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1178186665","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178186665?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 19:29","pubTimestamp":1782818945,"startTime":"0","endTime":"0","summary":"要点法国生物科技公司 Abivax 公布，其实验性药物 obefazimod 的最新数据显示，恶性肿瘤发生率与预期背景发生率一致，推动公司股价周二盘前大幅上涨。法国生物科技公司 Abivax 周二股价大涨，此前公司公布了其治疗炎症性肠病核心候选药物的最新数据。Abivax 股价盘前上涨35%。Abivax 表示，公司仍计划于2026年第四季度向美国食品药品监督管理局提交 obefazimod 的新药上市申请。","market":"us","thumbnail":"https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"法国生物科技公司Abivax盘前飙升35%，实验性药物最新数据提振市场信心","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4605","BK4515","ABVX","BK4534","BK4141","BK4588","BK4581","BK4566","BK4604","BK4602","BK4585","BK4553","BK4575","BK4148","BK4579","BK4532","BK4612","BK4170","BK4529","BK4550","BK4535","BK4533","BK4527","BK4512","BK4543","BK4554","BK4020"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1179173462","title":"焦點股追蹤：Strategy、超微電腦、星座品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=1179173462","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179173462?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 17:41","pubTimestamp":1782812476,"startTime":"0","endTime":"0","summary":"Strategy的股价在盘前交易中下跌超过3%，势将抹去昨日13%涨幅中的一部分。这家由迈克尔·塞勒执掌、以囤积比特币闻名的公司，周一宣布放弃其“永不卖出比特币”的信条，以期提振市场信心，此举引发了股价的剧烈波动。与人工智能基础设施建设相关的公司股票在盘前走高，投资者正重新涌入科技板块。超微电脑、应用材料和闪迪的股价均录得上扬。其股价小幅走高。酒精饮料巨头星座品牌将在开盘前公布季度业绩。耐克则将在收盘后发布财报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4595","LU1861220033.SGD","07399","LU0786609619.USD","LU1868836591.USD","SMCL","3SMI.UK","LU2089985449.USD","LU0310800965.SGD","LU0175139822.USD","LU0096362180.USD","ABVX","MSST","LU1989773731.SGD","BK4581","BK4519","LU2028103732.USD","LU0708994859.HKD","IE00BFXG0V08.USD","SNXX","IE00BQXX3D17.EUR","WNTR","LU0053671581.USD","MSTK","BK4600","BK4533","LU1861215975.USD","BK4169","BK4596","LU0081259029.USD","BK4023","LU2089283258.USD","LU2023250843.SGD","BK4516","BK4534","LU0011850046.USD","BK4170","LU2023250504.SGD","MSOO","LU0661504455.SGD","LU1778281490.HKD","LU2552382215.SGD","BK4559","LU0029864427.USD","LU0963586101.USD","BK4561","LU1267930813.SGD","BK4146","LU1674673691.USD","LU0354030511.USD","BK4518","LU0061475181.USD","LU1721428933.USD","LU0096364046.USD","LU0054578231.USD","LU1815336760.USD","SNDK","LU0079474960.USD","IMST","LU0158827948.USD","LU0444973449.USD","IE00BYQQ9H92.USD","LU0545039389.USD","LU0097036916.USD","IE0009356076.USD","LMI3.UK","GB00BDT5M118.USD","LU0348723411.USD","LU0289960550.SGD","BK4543","LU2111349929.HKD","MTYY","LU0949170772.SGD","LU0957808578.USD","IE00BD6J9T35.USD","MSII","LU2552382132.HKD","LU1815333072.USD","SNDU","MSDD","LU0823411888.USD","LU1803068979.SGD","MSTU","LU2458330169.SGD","LU0128525689.USD","IE00BQXX3F31.USD","SMI3.UK","LU0274383776.USD","LU1069344957.HKD","LU1267930227.SGD","SG9999001424.SGD","LU0957791311.USD","LU1868837300.USD","MSTZ","SMCY","AMAT","LU1868836914.USD","MSTY","SG9999002232.USD","MSTX","09399","09799","LU1003077747.HKD","LU0889566641.SGD","LU2023251221.USD","LU1868836757.USD","LU2271345857.HKD","SMCC","LU1989763005.USD","LU0738911758.USD","LU2098885051.SGD","LU0109392836.USD","LU1974910355.USD","LU1035775433.USD","BK4504","APED","MST","SMCI","07799","NKE","LU1674673428.USD","SG9999002224.SGD","SMST","IE00BSNM7G36.USD","BK4147","BK4585","LU0942090050.USD","LU1868837136.USD","LU0444971666.USD","LU1642822529.SGD","LU1046421795.USD","LU0889565833.HKD","LU2552382058.USD","LU0310800379.SGD","LU1823568750.SGD","3LMI.UK","BK4139","LU0476273544.USD","04336","MSTP","SMCZ","LU0238689110.USD","LU0868494617.USD","SMYY","LU0347712357.USD","BK4588","LU0052756011.USD","LU0061474960.USD","LU2360107168.USD","LU0198837287.USD","LU2106854487.HKD","LU2413666426.HKD","MSTY.UK","LU2290526834.HKD","MSTR","LU2931357623.SGD","LU1153585028.USD","BK4567","LU2458330243.SGD","SMCX","IE00BQXX3C00.GBP","LU0792757196.USD","LU0868494708.USD","BK4558","LU1917777945.USD","LU0158827781.USD","LU1303367103.USD","MSTW","LU2413666699.HKD","IE00BFXG1179.USD","BK4566","LU0354030438.USD","LU2089284900.SGD","LU1267930573.SGD","LU0128525929.USD","IE00B5949003.HKD","STZ","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123996127","title":"異動解讀｜Abivax S.A.盤前上漲25.85%，三期維持試驗補充數據積極驅動股價加速反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=1123996127","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123996127?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 16:00","pubTimestamp":1782806448,"startTime":"0","endTime":"0","summary":"6月30日，Abivax S.A.盘前上涨25.85%，报120.33美元/股，成交额2.18万美元。此前50mg组曾因报告多例癌症病例致股价从130美元附近暴跌至约70美元，跌幅一度近50%。本次补充数据确认疗效并消除安全性新增隐患，前期争议逐步消化，多头情绪加速升温，股价持续回补前期跌幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}